1. World Health Organization.Coronavirus disease (COVID‐19).https://www.who.int/health‐topics/coronavirus. Accessed March 22 2022.
2. Critical review and analysis of approval of favipiravir for restricted emergency use in mild-to-moderate COVID-19
3. Food and Drug Administration.Remdesivir (Veklury).https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214787Orig1s000lbl.pdf. Published 2020. Accessed March 26 2022.
4. Food and Drug Administration.Fact sheet for healthcare providers: Emergency Use Authorization (EUA) for molnupiravir.https://www.fda.gov/media/155054/download. Published 2022. Accessed March 26 2022.
5. Food and Drug Administration.Fact sheet for healthcare providers: Emergency Use Authorization (EUA) for paxlovid.https://www.fda.gov/media/155050/download. Published 2021. Accessed March 26 2022.